Loeb Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Loeb Partners's AMGN Position: Q1 2019 in Review
Loeb Partners sold out of Amgen (AMGN) in Q1 2019, closing a stake of 6,000 shares — an estimated $1.17M sold.
Loeb Partners first reported a position in AMGN in Q2 2016 and held it in 9 quarters. The position peaked at $1.94M in Q2 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.
- Loeb Partners reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
- Loeb Partners sold 6,000 Amgen shares in Q1 2019, an estimated $1.17M.
- Loeb Partners first reported a position in Amgen in Q2 2016 and held it in 9 quarters.
- Loeb Partners's Amgen position peaked at $1.94M in Q2 2018.
- 1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.
Based on Loeb Partners's 13F filing for Q1 2019, filed 14 May 2019.